Sector
PharmaceuticalsOpen
₹313Prev. Close
₹308Turnover(Lac.)
₹40.86Day's High
₹321.75Day's Low
₹29752 Week's High
₹41752 Week's Low
₹107Book Value
₹35.21Face Value
₹10Mkt Cap (₹ Cr.)
381.43P/E
0EPS
0Divi. Yield
022 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
8 Sep 2023
12:00 AM
BookCloser
24 Nov 2023
12:00 AM
EGM
31 Aug 2023
12:00 AM
AGM
Announcement Date: 31 Aug, 2023
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 10.56 | 10.56 | 10.56 | 10.56 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 3.98 | 0.72 | -0.51 | 4.11 |
Net Worth | 14.54 | 11.28 | 10.05 | 14.67 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 43.2 | 53.68 | 43.76 | 39.61 |
yoy growth (%) | -19.52 | 22.65 | 10.47 | 21.88 |
Raw materials | -14.57 | -13.61 | -9.55 | -9.19 |
As % of sales | 33.72 | 25.36 | 21.83 | 23.2 |
Employee costs | -13.06 | -16.02 | -12.82 | -11.33 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -6.57 | 1.21 | 3.4 | 3.23 |
Depreciation | -0.81 | -0.67 | -0.5 | -0.56 |
Tax paid | 1.62 | -0.33 | -1.1 | -1.02 |
Working capital | 0.44 | -18.69 | 19.58 | 4.58 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -19.52 | 22.65 | 10.47 | 21.88 |
Op profit growth | -96.11 | -43.12 | 11.78 | 20.74 |
EBIT growth | -121.69 | -50.88 | 17.13 | 21.95 |
Net profit growth | -664.56 | -61.88 | 4.42 | 27.63 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 107.44 | 93.41 | 80.35 | 62.07 | 76.64 |
Excise Duty | 5.1 | 4.17 | 4.08 | 3.1 | 3.6 |
Net Sales | 102.34 | 89.24 | 76.27 | 58.97 | 73.03 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 0.93 | 3.12 | 1.14 | 0.11 | 0.16 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.45 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,520.1 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.15 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.6 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,639.05 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman (Non-Executive)
Ramesh Vangal
Whole-time Director
K Anilkumar
Non Executive Director
Anand Subramanian
Independent Director
Harish Menon
Non Executive Director
Gokul Patnaik
Independent Director
S Krishnamurthy
Independent Director
Shilpa Kiran Gududur
Independent Director
Rajesh Sharma
Company Sec. & Compli. Officer
Jyothi Gulecha
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Kerala Ayurveda Ltd
Summary
Kerala Ayurveda Ltd was established on 6th July 1992. The Company is engaged in manufacture of Ayurveda products, Ayurveda Research, Academies, Clinics, Hospitals, Ayurvedic Wellness Resorts and Services , cultivation of herbs and maintaining herbarium of medicinal plants. The Company emerged as a frontline manufacturer of speciality patent ayurvedic medicines - tussnil, liposem and mathrukalpam. The company came out with a public issue in Feb.95 to part-finance its 7-cr expansion-cum-diversification programme which involve, expansion of its existing facilities; to develop a fully integrated health care system, cultivate medicinal plants and market ayurvedic medicines. It also envisions setting up a hospital. A modern facility to manufacture patent medicines, tablets, capsules and syrups, is to be set up at Athani, near Alwaye. The company is in the midst of enhancing the installed capacity at its Athani plant to produce traditional ayurvedic medicines. Moreover, the company proposes to organise and relocate its twelve clinics to cover all the principal districts in Kerala and augment facilities at its clinics in Bombay, Madras, Bangalore and Mangalore. In addition, it is increasing the bed strength of its hospital in Alwaye.Kerala Ayurvedic has won the approval of the Karnataka Toursim Development Department to open a health resort at Bangalore catering exclusively to the high income segments, tourists and NRIs.The company has a well-entrenched presence in several states due
Read More
What is the Kerala Ayurveda Ltd share price today?
The Kerala Ayurveda Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹317 today.
What is the Market Cap of Kerala Ayurveda Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Kerala Ayurveda Ltd is ₹381.43 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Kerala Ayurveda Ltd?
The PE and PB ratios of Kerala Ayurveda Ltd is 0 and 8.75 as of 22 Jul ‘24
What is the 52 Week High and Low of Kerala Ayurveda Ltd?
The 52-week high/low is the highest and lowest price at which a Kerala Ayurveda Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Kerala Ayurveda Ltd is ₹107 and ₹417 as of 22 Jul ‘24
What is the CAGR of Kerala Ayurveda Ltd?
Kerala Ayurveda Ltd's CAGR for 5 Years at 41.73%, 3 Years at 64.06%, 1 Year at 168.53%, 6 Month at 2.65%, 3 Month at 12.88% and 1 Month at 2.84%.
What is the shareholding pattern of Kerala Ayurveda Ltd?
The shareholding pattern of Kerala Ayurveda Ltd is as follows:
Promoters - 58.58 %
Institutions - 0.04 %
Public - 41.38 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
